Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,193) with videos related to
Page
of 120
Sort By:
Pregnancy Hypertension
|
July 18, 2020
Blood pressure postpartum (BP<sup>2</sup>) RCT protocol: Follow-up and lifestyle behaviour change strategies in the first 12 months after hypertensive pregnancy
Amanda Henry, Clare Arnott, Angela Makris, et al.
Journal of the American Society of Nephrology : JASN
|
October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
Robert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association
|
June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials
Robert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
Alimentary Pharmacology & Therapeutics
|
June 16, 2025
Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland
Alexander T Elford, Nathan Constantine-Cooke, Phil W Jenkinson, et al.
IBRO Neuroscience Reports
|
January 31, 2024
Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study
Sondos Ayyash, Andrew D Davis, Gésine L Alders, et al.
Viruses
|
September 23, 2022
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
Kerri Basile, Rebecca J Rockett, Kenneth McPhie, et al.
Journal of Crohn'S & Colitis
|
June 5, 2021
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts
Lauranne A A P Derikx, Heather W Dolby, Nikolas Plevris, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008)
G T Ho, A Mowat, L Potts, et al.
Journal of Molecular Biology
|
March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies
Homer Pantua, Jingyu Diao, Mark Ultsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Jennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Page
of 120
Search research articles
Search
Showing results (1061-1070 of 1,193) with videos related to
Sort By:
Page
of 120
Pregnancy Hypertension
|
July 18, 2020
Blood pressure postpartum (BP<sup>2</sup>) RCT protocol: Follow-up and lifestyle behaviour change strategies in the first 12 months after hypertensive pregnancy
Amanda Henry, Clare Arnott, Angela Makris, et al.
Journal of the American Society of Nephrology : JASN
|
October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
Robert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association
|
June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials
Robert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
Alimentary Pharmacology & Therapeutics
|
June 16, 2025
Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland
Alexander T Elford, Nathan Constantine-Cooke, Phil W Jenkinson, et al.
IBRO Neuroscience Reports
|
January 31, 2024
Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study
Sondos Ayyash, Andrew D Davis, Gésine L Alders, et al.
Viruses
|
September 23, 2022
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
Kerri Basile, Rebecca J Rockett, Kenneth McPhie, et al.
Journal of Crohn'S & Colitis
|
June 5, 2021
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts
Lauranne A A P Derikx, Heather W Dolby, Nikolas Plevris, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008)
G T Ho, A Mowat, L Potts, et al.
Journal of Molecular Biology
|
March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies
Homer Pantua, Jingyu Diao, Mark Ultsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Jennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Page
of 120